NCT05324215

Brief Summary

Transversalis fascia plane block (TFPB) is a relatively new, easy-to-apply and safe regional anesthesia technique used to provide postoperative analgesia in various surgeries. It has been shown that TFPB and rectus sheath block (RSB) administration reduces opioid consumption and related side effects in patients undergoing surgery with general anesthesia. To our knowledge, there is no study examining TFPB in donor nephrectomy. The investigators aimed to prospectively examine the effect of TFPB and RSB on opioid consumption in postoperative period on donors who will undergo laparoscopic nephrectomy in renal transplantation surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at below P25 for not_applicable postoperative-pain

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 17, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 12, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 17, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 17, 2023

Completed
Last Updated

April 18, 2022

Status Verified

April 1, 2022

Enrollment Period

1 year

First QC Date

April 5, 2022

Last Update Submit

April 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total opioid consumption retrieved from patient records

    the amount of fentanyl required by the patient and given by the device will be recorded for the first 24 hours.

    up to 24 hours

Secondary Outcomes (1)

  • Numeric Rating Scale (NRS)

    up to 24 hours

Study Arms (2)

Transversalis Fascia Plane Block and Rectus Sheath Block Group

ACTIVE COMPARATOR

Transversalis Fascia Plane Block and Rectus Sheath Block will be administered to this group.

Procedure: Transversalis fascia plane block and rectus sheath blockDevice: Intravenous fentanyl patient control device

Control Group

SHAM COMPARATOR

No regional anesthesia technique will be applied to the control group.

Device: Intravenous fentanyl patient control device

Interventions

Transversalis fascia plane block and rectus sheath block will be administered after the surgery.

Transversalis Fascia Plane Block and Rectus Sheath Block Group

24-hour fentanyl consumption will be recorded.

Control GroupTransversalis Fascia Plane Block and Rectus Sheath Block Group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Donor patients scheduled for elective nephrectomy in renal transplantation surgery
  • American Society of Anesthesiologists (ASA) I-II
  • Patients who are aged between 18-75

You may not qualify if:

  • Skin infection at the block area
  • Coagulation disorder and using anticoagulant drugs
  • End-stage organ and system failure
  • Severe pulmonary and/or cardiovascular problems
  • Substance addiction or known psychiatric or mental problems
  • Chronic painkiller usage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Koç University Hospital

Istanbul, Zeytinburnu, 34010, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Central Study Contacts

Özlem Özkalaycı, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 5, 2022

First Posted

April 12, 2022

Study Start

February 17, 2022

Primary Completion

February 17, 2023

Study Completion

February 17, 2023

Last Updated

April 18, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations